Raia Drogasil S.A.
RADLY
$4.54
-$0.04-0.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.78% | 14.83% | 2.83% | -6.59% | -4.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.78% | 14.83% | 2.83% | -6.59% | -4.22% |
| Cost of Revenue | 30.17% | 15.33% | 3.88% | -5.89% | -3.64% |
| Gross Profit | 28.86% | 13.65% | 0.40% | -8.30% | -5.58% |
| SG&A Expenses | 23.65% | 12.76% | 0.63% | -4.46% | -5.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -88.52% | -5,434.94% | -- |
| Total Operating Expenses | 28.49% | 14.69% | 2.98% | -5.92% | -3.27% |
| Operating Income | 53.17% | 16.88% | 0.66% | -17.62% | -18.75% |
| Income Before Tax | 16.30% | 25.77% | -11.57% | -39.48% | -19.06% |
| Income Tax Expenses | 120.08% | -17.07% | -82.10% | -65.57% | -437.37% |
| Earnings from Continuing Operations | -10.22% | 38.63% | 7.15% | -27.78% | 6.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12,761.84% | -91.34% | -302.91% | 82.86% | 100.59% |
| Net Income | -5.81% | 37.98% | 5.31% | -26.17% | 13.74% |
| EBIT | 53.17% | 16.88% | 0.66% | -17.62% | -18.75% |
| EBITDA | 54.64% | 14.61% | 2.15% | -14.98% | -15.94% |
| EPS Basic | 2.53% | 38.16% | 83.64% | -26.11% | 18.27% |
| Normalized Basic EPS | 39.71% | 7.58% | 49.41% | -28.08% | -16.05% |
| EPS Diluted | 2.25% | 37.82% | 82.71% | -25.56% | 18.27% |
| Normalized Diluted EPS | 39.22% | 7.22% | 48.24% | -27.36% | -16.05% |
| Average Basic Shares Outstanding | -7.96% | -0.10% | -42.57% | -0.15% | -3.84% |
| Average Diluted Shares Outstanding | -7.72% | 0.11% | -42.26% | -0.80% | -3.84% |
| Dividend Per Share | -- | -34.80% | -- | -- | -- |
| Payout Ratio | 0.68% | -0.95% | 0.13% | -0.40% | -0.27% |